Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial
PaperCitations, authors & open-access status
Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 10 citations, 2016 year and bronze oa status.
10
Citations
2016
Year
bronze
OA Status